CROSSJECT (EPA:ALCJ) | WebDisclosure

Basculer en Français

9560	Companies
188837	Keywords
120585	Articles
100787	Press releases

Home
Companies
CROSSJECT

PRESS RELEASE

published on 09/22/2025 at 07:30, 2 months 28 days ago

CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental and FDA Authorization of the ZEPIZURE® (ZENEO® Midazolam)
CROSSJECT secures $11.3 million BARDA funding for ZEPIZURE® development towards FDA authorization. Advances include validation batches and facility audit completion

BARDA Funding Crossject FDA Authorization ZEPIZURE Development Emergency Auto-injectors
PRESS RELEASE

published on 09/22/2025 at 07:30, 2 months 28 days ago

CROSSJECT obtient un financement supplémentaire de la BARDA pour soutenir le développement et l'autorisation par la FDA de ZEPIZURE®
CROSSJECT obtient un financement supplémentaire de 11,3 millions de dollars de la BARDA pour le développement de ZEPIZURE® approuvé par la FDA

FDA Financement Crossject ZEPIZURE BARDA
BRIEF

published on 07/01/2025 at 07:35, 5 months 19 days ago

Change of liquidity contract for CROSSJECT

Liquidity Euronext Pharmaceutical Contract Crossject
BRIEF

published on 07/01/2025 at 07:35, 5 months 19 days ago

Changement de contrat de liquidité pour CROSSJECT

Contrat Euronext Liquidité Pharmaceutique Crossject
PRESS RELEASE

published on 07/01/2025 at 07:30, 5 months 19 days ago

CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité
CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité avec Rothschild Martin Maurel pour favoriser la liquidité des transactions. Détails du contrat et impacts sur le marché réglementé d'Euronext

Contrat De Liquidité Rothschild Martin Maurel Euronext Crossject ZENEO®
BRIEF

published on 06/24/2025 at 19:05, 5 months 25 days ago

CROSSJECT obtient une augmentation de capital de 5,7 millions d'euros

Augmentation De Capital Soumission À La FDA ZEPIZURE® Gemmes Venture Vatel Capital
BRIEF

published on 06/24/2025 at 19:05, 5 months 25 days ago

CROSSJECT Secures €5.7 Million in Capital Increase

Capital Increase FDA Submission ZEPIZURE® Gemmes Venture Vatel Capital
PRESS RELEASE

published on 06/24/2025 at 19:00, 5 months 25 days ago

CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause
CROSSJECT successfully completes a capital increase of €5.7 million through preferential subscription rights, benefiting from new investor support and Gemmes Venture, to advance ZEPIZURE® development

Capital Increase Crossject ZEPIZURE® Gemmes Venture Vatel Capital
PRESS RELEASE

published on 06/24/2025 at 19:00, 5 months 25 days ago

CROSSJECT annonce le vif succès de son augmentation de capital portée à 5,7 millions d’euros après exercice intégral de la clause d’extension
CROSSJECT annonce le vif succès de son augmentation de capital à 5,7 millions d’euros après exercice intégral de la clause d’extension pour ZEPIZURE®

Financement Augmentation De Capital Pharmaceutique Crossject ZEPIZURE
BRIEF

published on 06/11/2025 at 07:35, 6 months 9 days ago

CROSSJECT advances in the development of ZEPIZURE® Junior for children

Epilepsy Pediatrics Crossject Auto-injector ZEPIZURE Junior

Accesswire

Published on 12/20/2025 at 00:30, 11 hours 42 minutes ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 14 hours 12 minutes ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 17 hours 42 minutes ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 21 hours 32 minutes ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 22 hours 42 minutes ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE

EQS Group

Published on 12/20/2025 at 10:05, 2 hours 6 minutes ago

FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 14 hours 9 minutes ago

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 14 hours 31 minutes ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 15 hours 36 minutes ago

Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
Published on 12/19/2025 at 20:15, 15 hours 56 minutes ago

CSDS EU RNS Name Changes (19 December 2025)

Les Echos

Published on 12/19/2025 at 21:57, 14 hours 14 minutes ago

Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 1 day 3 hours ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 1 day 3 hours ago

Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 1 day 5 hours ago

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 1 day 5 hours ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

View all LES ECHOS COMFI WIRE